Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
PLoS Genet ; 10(11): e1004711, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25392908

RESUMO

Aldolase A deficiency has been reported as a rare cause of hemolytic anemia occasionally associated with myopathy. We identified a deleterious homozygous mutation in the ALDOA gene in 3 siblings with episodic rhabdomyolysis without hemolytic anemia. Myoglobinuria was always triggered by febrile illnesses. We show that the underlying mechanism involves an exacerbation of aldolase A deficiency at high temperatures that affected myoblasts but not erythrocytes. The aldolase A deficiency was rescued by arginine supplementation in vitro but not by glycerol, betaine or benzylhydantoin, three other known chaperones, suggesting that arginine-mediated rescue operated by a mechanism other than protein chaperoning. Lipid droplets accumulated in patient myoblasts relative to control and this was increased by cytokines, and reduced by dexamethasone. Our results expand the clinical spectrum of aldolase A deficiency to isolated temperature-dependent rhabdomyolysis, and suggest that thermolability may be tissue specific. We also propose a treatment for this severe disease.


Assuntos
Febre/genética , Frutose-Bifosfato Aldolase/genética , Doença de Depósito de Glicogênio/genética , Rabdomiólise/genética , Anemia Hemolítica/genética , Anemia Hemolítica/patologia , Arginina/metabolismo , Dexametasona/administração & dosagem , Eritrócitos/patologia , Feminino , Febre/etiologia , Febre/patologia , Frutose-Bifosfato Aldolase/química , Doença de Depósito de Glicogênio/patologia , Glicólise , Humanos , Masculino , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/patologia , Mioblastos/metabolismo , Mioblastos/patologia , Linhagem , Conformação Proteica , Rabdomiólise/etiologia , Rabdomiólise/patologia
2.
Muscle Nerve ; 52(5): 895-9, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25959956

RESUMO

INTRODUCTION: Cylindrical spirals are characteristic muscular inclusions consisting of spiraling double-laminated membranes. They are found in heterogeneous clinical conditions. METHODS: We obtained muscle biopsies from 2 young sisters with severe congenital hypotonia, muscle weakness, and epileptic encephalopathy, and identified cylindrical spirals. RESULTS: We found an association between congenital encephalomyopathy and cylindrical spirals. CONCLUSIONS: In this morphological and ultrastructural study, we speculate on the origin of these peculiar structures.


Assuntos
Hiperventilação/complicações , Hiperventilação/diagnóstico , Deficiência Intelectual/complicações , Deficiência Intelectual/diagnóstico , Debilidade Muscular/complicações , Debilidade Muscular/diagnóstico , Sarcolema/patologia , Adolescente , Criança , Fácies , Feminino , Humanos , Doenças Musculares/complicações , Doenças Musculares/diagnóstico
3.
Biochim Biophys Acta ; 1832(12): 2103-14, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23928362

RESUMO

Lipin-1 deficiency is associated with massive rhabdomyolysis episodes in humans, precipitated by febrile illnesses. Despite well-known roles of lipin-1 in lipid biosynthesis and transcriptional regulation, the pathogenic mechanisms leading to rhabdomyolysis remain unknown. Here we show that primary myoblasts from lipin-1-deficient patients exhibit a dramatic decrease in LPIN1 expression and phosphatidic acid phosphatase 1 activity, and a significant accumulation of lipid droplets (LD). The expression levels of LPIN1-target genes [peroxisome proliferator-activated receptors delta and alpha (PPARδ, PPARα), peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), acyl-coenzyme A dehydrogenase, very long (ACADVL), carnitine palmitoyltransferase IB and 2 (CPT1B and CPT2)] were not affected while lipin-2 protein level, a closely related member of the family, was increased. Microarray analysis of patients' myotubes identified 19 down-regulated and 51 up-regulated genes, indicating pleiotropic effects of lipin-1 deficiency. Special attention was paid to the up-regulated ACACB (acetyl-CoA carboxylase beta), a key enzyme in the fatty acid synthesis/oxidation balance. We demonstrated that overexpression of ACACB was associated with free fatty acid accumulation in patients' myoblasts whereas malonyl-carnitine (as a measure of malonyl-CoA) and CPT1 activity were in the normal range in basal conditions accordingly to the normal daily activity reported by the patients. Remarkably ACACB invalidation in patients' myoblasts decreased LD number and size while LPIN1 invalidation in controls induced LD accumulation. Further, pro-inflammatory treatments tumor necrosis factor alpha+Interleukin-1beta(TNF1α+IL-1ß) designed to mimic febrile illness, resulted in increased malonyl-carnitine levels, reduced CPT1 activity and enhanced LD accumulation, a phenomenon reversed by dexamethasone and TNFα or IL-1ß inhibitors. Our data suggest that the pathogenic mechanism of rhabdomyolysis in lipin-1-deficient patients combines the predisposing constitutive impairment of lipid metabolism and its exacerbation by pro-inflammatory cytokines.


Assuntos
Citocinas/farmacologia , Mediadores da Inflamação/farmacologia , Transtornos do Metabolismo dos Lipídeos/etiologia , Lipídeos , Fibras Musculares Esqueléticas/patologia , Mioblastos/patologia , Fosfatidato Fosfatase/genética , Biomarcadores/metabolismo , Western Blotting , Estudos de Casos e Controles , Ciclo Celular , Proliferação de Células , Criança , Pré-Escolar , Estresse do Retículo Endoplasmático , Feminino , Perfilação da Expressão Gênica , Humanos , Transtornos do Metabolismo dos Lipídeos/metabolismo , Transtornos do Metabolismo dos Lipídeos/patologia , Masculino , Fibras Musculares Esqueléticas/efeitos dos fármacos , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Mutação/genética , Mioblastos/efeitos dos fármacos , Mioblastos/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos , Proteínas Associadas a Pancreatite , Fosfatidato Fosfatase/metabolismo , RNA Mensageiro/genética , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Rabdomiólise/etiologia , Rabdomiólise/metabolismo , Rabdomiólise/patologia
4.
Hum Mol Genet ; 19(24): 4820-36, 2010 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-20858595

RESUMO

Autosomal dominant centronuclear myopathy (AD-CNM) is due to mutations in the gene encoding dynamin 2 (DNM2) involved in endocytosis and intracellular membrane trafficking. To understand the pathomechanisms resulting from a DNM2 mutation, we generated a knock-in mouse model expressing the most frequent AD-CNM mutation (KI-Dnm2(R465W)). Heterozygous (HTZ) mice developed a myopathy showing a specific spatial and temporal muscle involvement. In the primarily and prominently affected tibialis anterior muscle, impairment of the contractile properties was evidenced at weaning and was progressively associated with atrophy and histopathological abnormalities mainly affecting mitochondria and reticular network. Expression of genes involved in ubiquitin-proteosome and autophagy pathways was up-regulated during DNM2-induced atrophy. In isolated muscle fibers from wild-type and HTZ mice, Dnm2 localized in regions of intense membrane trafficking (I-band and perinuclear region), emphasizing the pathophysiological hypothesis in which DNM2-dependent trafficking would be altered. In addition, HTZ fibers showed an increased calcium concentration as well as an intracellular Dnm2 and dysferlin accumulation. A similar dysferlin retention, never reported so far in congenital myopathies, was also demonstrated in biopsies from DNM2-CNM patients and can be considered as a new marker to orientate direct genetic testing. Homozygous (HMZ) mice died during the first hours of life. Impairment of clathrin-mediated endocytosis, demonstrated in HMZ embryonic fibroblasts, could be the cause of lethality. Overall, this first mouse model of DNM2-related myopathy shows the crucial role of DNM2 in muscle homeostasis and will be a precious tool to study DNM2 functions in muscle, pathomechanisms of DNM2-CNM and developing therapeutic strategies.


Assuntos
Dinamina II/genética , Músculo Esquelético/patologia , Músculo Esquelético/fisiopatologia , Mutação/genética , Miopatias Congênitas Estruturais/genética , Miopatias Congênitas Estruturais/fisiopatologia , Animais , Comportamento Animal , Cálcio/metabolismo , Disferlina , Embrião de Mamíferos/patologia , Fibroblastos/metabolismo , Fibroblastos/patologia , Heterozigoto , Homozigoto , Humanos , Imuno-Histoquímica , Proteínas de Membrana/metabolismo , Camundongos , Camundongos Transgênicos , Atividade Motora/fisiologia , Contração Muscular/fisiologia , Proteínas Musculares/metabolismo , Debilidade Muscular/complicações , Debilidade Muscular/patologia , Debilidade Muscular/fisiopatologia , Músculo Esquelético/ultraestrutura , Atrofia Muscular/complicações , Atrofia Muscular/patologia , Atrofia Muscular/fisiopatologia , Fenótipo , Transporte Proteico , Frações Subcelulares/metabolismo
5.
Acta Neuropathol Commun ; 2: 44, 2014 Apr 12.
Artigo em Inglês | MEDLINE | ID: mdl-24725366

RESUMO

Nemaline myopathy (NM) is a rare congenital myopathy characterised by hypotonia, muscle weakness, and often skeletal muscle deformities with the presence of nemaline bodies (rods) in the muscle biopsy. The nebulin (NEB) gene is the most commonly mutated and is thought to account for approximately 50% of genetically diagnosed cases of NM. We undertook a detailed muscle morphological analysis of 14 NEB-mutated NM patients with different clinical forms to define muscle pathological patterns and correlate them with clinical course and genotype. Three groups were identified according to clinical severity. Group 1 (n = 5) comprises severe/lethal NM and biopsy in the first days of life. Group 2 (n = 4) includes intermediate NM and biopsy in infancy. Group 3 (n = 5) comprises typical/mild NM and biopsy in childhood or early adult life. Biopsies underwent histoenzymological, immunohistochemical and ultrastructural analysis. Fibre type distribution patterns, rod characteristics, distribution and localization were investigated. Contractile performance was studied in muscle fibre preparations isolated from seven muscle biopsies from each of the three groups. G1 showed significant myofibrillar dissociation and smallness with scattered globular rods in one third of fibres; there was no type 1 predominance. G2 presented milder sarcomeric dissociation, dispersed or clustered nemaline bodies, and type 1 predominance/uniformity. In contrast, G3 had well-delimited clusters of subsarcolemmal elongated rods and type 1 uniformity without sarcomeric alterations. In accordance with the clinical and morphological data, functional studies revealed markedly low forces in muscle bundles from G1 and a better contractile performance in muscle bundles from biopsies of patients from G2, and G3.In conclusion NEB-mutated NM patients present a wide spectrum of morphological features. It is difficult to establish firm genotype phenotype correlation. Interestingly, there was a correlation between clinical severity on the one hand and the degree of sarcomeric dissociation and contractility efficiency on the other. By contrast the percentage of fibres occupied by rods, as well as the quantity and the sub sarcolemmal position of rods, appears to inversely correlate with severity. Based on our observations, we propose myofibrillar dissociation and changes in contractility as an important cause of muscle weakness in NEB-mutated NM patients.


Assuntos
Proteínas Musculares/genética , Músculos/patologia , Músculos/ultraestrutura , Miopatias da Nemalina/genética , Miopatias da Nemalina/patologia , Adolescente , Criança , Pré-Escolar , Análise Mutacional de DNA , Feminino , Genótipo , Humanos , Lactente , Recém-Nascido , Masculino , Microscopia Eletrônica , Contração Muscular/genética , Debilidade Muscular/etiologia , Miopatias da Nemalina/complicações , Cadeias Pesadas de Miosina/metabolismo , Miosinas/metabolismo , Índice de Gravidade de Doença , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA